Study for Patients With Non Small Cell Lung Cancer (NSCLC)

NCT00168883 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: Vinorelbine

Sponsor

Charite University, Berlin, Germany

Collaborators

[object Object]
[object Object]